Literature DB >> 28734141

New dinuclear palladium(II) complexes: Studies of the nucleophilic substitution reactions, DNA/BSA interactions and cytotoxic activity.

Dušan Ćoćić1, Snežana Jovanović1, Marija Nišavić2, Dejan Baskić3, Danijela Todorović4, Suzana Popović5, Živadin D Bugarčić1, Biljana Petrović6.   

Abstract

Six new dinuclear Pd(II) complexes, [{Pd(2,2'-bipy)Cl}2(μ-pz)](ClO4)2 (Pd1), [{Pd(dach)Cl}2(μ-pz)](ClO4)2 (Pd2), [{Pd(en)Cl}2(μ-pz)](ClO4)2 (Pd3), [{Pd(2,2'-bipy)Cl}2(μ-4,4'-bipy)](ClO4)2 (Pd4), [{Pd(dach)Cl}2(μ-4,4'-bipy)](ClO4)2 (Pd5) and [{Pd(en)Cl}2(μ-4,4'-bipy)](ClO4)2 (Pd6) (where 2,2'-bipy=2,2'-bipyridyl, pz=pyrazine, dach=trans-(±)-1,2-diaminocyclohexane, en=ethylenediamine, 4,4'-bipy=4,4'-bipyridyl) have been synthesized and characterized by elemental microanalysis, IR, 1H NMR and MALDI-TOF mass spectrometry. The pKa values of corresponding diaqua complexes were determined by spectrophotometric pH titration. Substitution reactions with thiourea (Tu), l-methionine (l-Met), l-cysteine (l-Cys), l-histidine (l-His) and guanosine-5'-monophosphate (5'-GMP) were studied under the pseudo-first order conditions at pH7.2. Reactions of Pd1 with Tu, l-Met and l-Cys were followed by decomposition of complexes, while structures of dinuclear complexes were preserved during the substitution with nitrogen donors. Interactions with calf-thymus DNA (CT-DNA) were followed by absorption spectroscopy and fluorescence quenching measurements. All complexes can bind to CT-DNA exhibiting high intrinsic binding constants (Kb=104-105M-1). Competitive studies with ethidium bromide (EB) have shown that complexes can displace DNA-bound EB. High values of binding constants towards bovine serum albumin protein (BSA) indicate good binding affinity. Finally, all complexes showed moderate to high cytotoxic activity against HeLa (human cervical epithelial carcinoma cell lines) and MDA-MB-231 (human breast epithelial carcinoma cell lines) tumor cell lines inducing apoptotic type cell death, whereas normal fibroblasts were significantly less sensitive. The impact on cell cycle of these cells was distinctive, where Pd4, Pd5 and Pd6 showed the most prominent effect arresting MDA-MB-231 (human lung fibroblast cell lines) cell in G1/S phase of cell cycle.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BSA; Cytotoxicity; DNA; Dinuclear Pd(II) complexes; Kinetics

Mesh:

Substances:

Year:  2017        PMID: 28734141     DOI: 10.1016/j.jinorgbio.2017.07.009

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  4 in total

1.  Synthesis, substitution kinetics, DNA/BSA binding and cytotoxicity of tridentate N^E^N (E = NH, O, S) pyrazolyl palladium(II) complexes.

Authors:  Reinner O Omondi; Adewale O Fadaka; Amos A Fatokun; Deogratius Jaganyi; Stephen O Ojwach
Journal:  J Biol Inorg Chem       Date:  2022-10-05       Impact factor: 3.862

2.  New dinuclear palladium(II) complexes with benzodiazines as bridging ligands: interactions with CT-DNA and BSA, and cytotoxic activity.

Authors:  Andjela A Franich; Marija D Živković; Dušan Ćoćić; Biljana Petrović; Marija Milovanović; Aleksandar Arsenijević; Jelena Milovanović; Dragana Arsenijević; Bojana Stojanović; Miloš I Djuran; Snežana Rajković
Journal:  J Biol Inorg Chem       Date:  2019-08-05       Impact factor: 3.358

3.  Synthesis, Characterization and Antiproliferative Evaluation of Pt(II) and Pd(II) Complexes with a Thiazine-Pyridine Derivative Ligand.

Authors:  Silvia Gutiérrez-Tarriño; Javier Espino; Francisco Luna-Giles; Ana B Rodríguez; José A Pariente; Emilio Viñuelas-Zahínos
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-22

4.  Synthesis and structure of a new thiazoline-based palladium(II) complex that promotes cytotoxicity and apoptosis of human promyelocytic leukemia HL-60 cells.

Authors:  Javier Espino; Elena Fernández-Delgado; Samuel Estirado; Felipe de la Cruz-Martinez; Sergio Villa-Carballar; Emilio Viñuelas-Zahínos; Francisco Luna-Giles; José A Pariente
Journal:  Sci Rep       Date:  2020-10-07       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.